Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

Series C

LeanTaas prises $40m from Goldman Sachs
NYP and Sedgwick-backed healthcare allocation software producer LeanTaas has now raised more than $100m in just over two years.
Perfect Day shines in $140m series C
The Continental Grain-backed vegan dairy product developer has captured $140m at a $440m valuation, with Temasek leading the round.
Carsome caches $50m
The Hubert Burda-backed second-hand car marketplace has now raised $85m in total, MUFG Innovation Partners and Daiwa PI Partners chipping in for its series C round.
WeLab produces $156m result
Alibaba Hong Kong Entrepreneurs Fund was one of five returning backers to reinvest in the online lending platform as part of its series C round.
Orange calls in on Intercloud
The cloud interconnect platform developer raised $24.2m from investors including Orange Digital Ventures, Open CNP, UL Invest and SNCF Digital Ventures.
LandSpace rockets to $71m series C
Country Garden Venture Capital led a round that will support the development and launch of 36Kr and Goldwind-backed LandSpace's next rocket model.
Mitsui enters Arcadia in $30m series C
Arcadia, the operator of a clean energy-sourcing platform for domestic use, boosted its overall equity funding to more than $62m in a Mitsui USA-backed round.
Imperative Care impresses with $79m
Ascension Ventures was among the participants in the first close of neurovascular catheter developer Imperative Care's series C round, which it expects to close at $85m.

Other News

Zentalis zips to $85m series C
Pharmaron-backed Zentalis Pharmaceuticals has now secured $147m altogether and will advance its breast cancer and solid tumour candidates through clinical trials.
Ribo rips into series C1 round
Legend Capital returned as the RNA drug developer secured $28.8m in a round co-led by Panlin Capital and Trinity Innovation Fund.
Nutriati heats up with series C funding
PLT Health Solutions and existing backer Tate & Lyle Ventures contributed to a $12.7m round for vegan ingredients supplier Nutriati to take its total funding to more than $22m.
Corporate venturing deal net: 2-6 December 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds
Figure finds $103m in series C round
MUFG Innovation Partners contributed to a round that boosted the valuation of the blockchain-based lending platform to $1.2bn.
Roche polishes Black Diamond's $85m series C
The cancer drug developer emerged from stealth with $194m in funding, $85m of which was just closed in a round featuring returning investor Roche Venture Fund.

Editor's Picks

Sub-$50m Investment of the Year: Maana
Maana recently won GCV’s inaugural award for energy-tech corporate venture capital (CVC) investment of the year, presented during its Venture Houston conference in November. Now, Maana has gone one-stage further and won the Sub-$50m Investment of the Year award across all industries.
Relay Therapeutics runs away with $400m
SoftBank Vision Fund led a series B round for the cancer therapy developer that was also backed by GV and Alexandria Venture Investments.
Zymergen climbs to $400m series C
The molecular product technology provider followed a nine-figure, SoftBank-led round two years ago with a series C led by the corporate's Vision Fund.
Plaid prises $250m from investors
The GV-backed financial software technology provider raised series C funding in a Kleiner Perkins-led round that valued it at $2.65bn.
test reg